PE firm Advent prepares takeover offer for UK's Tate & Lyle, FT reports
Adds shares in paragraph 2, details from FT report and background throughout
Oct 16 (Reuters) -Private equity firm Advent International is preparing a takeover offer for UK-based food and beverage ingredients maker Tate & Lyle TATE.L, the Financial Times reported on Wednesday, citing two people familiar with the discussions.
Shares in Tate & Lyle, which supplies ingredients for Splenda, the sweetener in Diet Coke and other sugar-free drinks, jumped 11.5% to a near eight-year high on the news.
The US-based buyout firm is in the early stages of its bid preparations, according to sources, who cautioned there was no certainty that a firm offer would be made, the report added.
The offer could value Tate & Lyle above its 2.8 billion pounds ($3.65 billion) market capitalization, according to the Financial Times.
Both Tate & Lyle and Advent declined to respond to Reuters' requests for comments.
Tate & Lyle in June agreed to buy U.S.-based CP Kelco for $1.8 billion to boost its speciality ingredients business and tap demand for plant-based products.
($1 = 0.7676 pounds)
Reporting by Prerna Bedi in Bengaluru, additional reporting by DhanushVignesh Babu; Editing by Shinjini Ganguli
Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
